Literature DB >> 2427443

Subset analysis of human class II molecules controlled by the DR2/Dw2 haplotype: two separate DR subsets carry the DR2 specificity.

N Tanigaki, R Tosi, G B Ferrara.   

Abstract

Human class II molecules were isolated from cells of a DR2/Dw2-homozygous cell line, PGF. The three mutually exclusive subsets were separated by selective binding with monoclonal antibody MCS7 and alloantisera CCB921 and KY22. The specificity involved in the binding with alloantisera was identified to be a supertypic specificity associated with DR1, 2, and w9 for CCB921 and the DQw1 specificity known to be associated with DR1, 2, w6, and w10 for KY22. The MCS7 specificity appeared to be a cross-reactive specificity related to the DRw52-like specificity. On peptide mapping, the alpha chains of MCS7- and CCB921-reactive subsets were the same, showing the pattern characteristic of DR alpha chains, whereas the beta chains were very similar to, but distinguishable from, each other. These structural features conformed to those of DR or DR-like subsets. The KY22-reactive subset was distinctive in both alpha and beta chains from the above two subsets, and it displayed peptide patterns typical to DQw1-bearing Ia molecules. Interestingly, the MCS7- and CCB921-reactive subsets both carried the DR2 specificity, as indicated by their binding to alloantiserum Fe73/22 which was proven to be DR2-specific.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427443     DOI: 10.1007/bf00373116

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  13 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay.

Authors:  K Koyama; K Nakamuro; N Tanigaki; D Pressman
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

3.  Structural organization of the DR subregion of the human major histocompatibility complex.

Authors:  T Spies; R Sorrentino; J M Boss; K Okada; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Polymorphism of human B-cell alloantigens: evidence for three loci within the HLA system.

Authors:  M L Markert; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Allelic polymorphism and complexity of the genes for HLA-DR beta-chains--direct analysis by DNA-DNA hybridization.

Authors:  C T Wake; E O Long; B Mach
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

7.  Assessment of the specificity of human Ia alloantisera and alloantigens by the use of radioiodinated human Ia antigens.

Authors:  N Tanigaki; R Tosi
Journal:  Tissue Antigens       Date:  1982-07

8.  Human class II major histocompatibility antigen beta-chains are derived from at least three loci.

Authors:  J Böhme; D Owerbach; M Denaro; A Lernmark; P A Peterson; L Rask
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

9.  The distribution of DR5, MT2, and MB3 specificities on human Ia subsets.

Authors:  N Tanigaki; R Tosi; K Sagawa; J Minowada; G B Ferrara
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

10.  Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line.

Authors:  N Tanigaki; R Tosi; R J Duquesnoy; G B Ferrara
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.